These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37713854)

  • 21. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
    Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
    Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical features of children with incomplete Kawasaki disease].
    Peng C; Luo YJ; Xing QL; Xiao MC
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Nov; 18(11):1111-1114. PubMed ID: 27817775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery lesion risk and mediating mechanism in children with complete and incomplete Kawasaki disease.
    Shi H; Qiu H; Jin Z; Li C; Yang X; Huang C; Wu R; Zhuang G; Chu M
    J Investig Med; 2019 Aug; 67(6):950-956. PubMed ID: 30804174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes and significance of oxidized phospholipids and endothelial nitric oxide synthase in the acute stage of Kawasaki disease].
    Zhu LR; He XH; Yuan YH; Yuan H; Xia XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug; 26(8):829-834. PubMed ID: 39148387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High risk of coronary artery aneurysm in Kawasaki disease.
    Mossberg M; Mohammad AJ; Kahn F; Segelmark M; Kahn R
    Rheumatology (Oxford); 2021 Apr; 60(4):1910-1914. PubMed ID: 33150451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
    Liu R; Gao F; Huo J; Yi Q
    Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features of children with Kawasaki disease aged over 5 years].
    Tian F; Zhang J; Xiao L
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Nov; 20(11):917-920. PubMed ID: 30477622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
    Xie LP; Yan WL; Huang M; Huang MR; Chen S; Huang GY; Liu F
    J Epidemiol; 2020 Oct; 30(10):429-435. PubMed ID: 31548437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incomplete Kawasaki disease in the 2-month-old infant: A case report.
    Ma W; Sun J; Wang H
    Medicine (Baltimore); 2018 Dec; 97(50):e13280. PubMed ID: 30557973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children With Kawasaki Disease.
    Chidambaram AC; Ramamoorthy JG; Anantharaj A
    Indian Pediatr; 2023 Mar; 60(3):207-211. PubMed ID: 36604937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new scoring system to predict Kawasaki disease with coronary artery lesions.
    Hua W; Ma F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Clin Rheumatol; 2019 Apr; 38(4):1099-1107. PubMed ID: 30523553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease.
    Xue M; Wang J
    Exp Ther Med; 2020 Apr; 19(4):2597-2603. PubMed ID: 32256739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Characteristics of Kawasaki Disease in Children with Different Age Groups: A Literature Review and Retrospective Study.
    Huang B; Tan W; Liao S; Jiang W
    Curr Pharm Des; 2023; 29(19):1516-1523. PubMed ID: 37303183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red blood cell distribution width and tumor necrosis factor-α for the early prediction of coronary artery lesion in Kawasaki disease: a retrospective study.
    Li J; Li DE; Hu M; Huang H; Xu S; Li H
    Eur J Pediatr; 2022 Mar; 181(3):903-909. PubMed ID: 34494160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.